Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa
Conditions
- Recessive Dystrophic Epidermolysis Bullosa
Interventions
- DRUG: Gene-modified autologous fibroblasts
Sponsor
King's College London
Collaborators